RILDINADSTROCEL
UNII 3ME9TTI5QB

Substance Identification & Data

This profile provides standardized clinical and technical data for Rildinadstrocel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3ME9TTI5QB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3ME9TTI5QB

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RILDINADSTROCEL

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190749

National Cancer Institute reference terminology for clinical and research data.

INN ID

12412

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-251

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

180092

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

9606

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rildinadstrocel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RILDINADSTROCEL

Common Names & Synonyms

ALLOGENEIC ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELLS (PSC-04)

ALLOGENEIC ADIPOSE-DERIVED MESENCHYMAL STROMAL CELLS (AD-MSCS)

ALLOGENIC ADIPOSE DERIVED MESENCHYMAL STEM CELLS (MSCS)

ALLOGENIC ADIPOSE DERIVED MESENCHYMAL STROMAL CELLS

ASTROSTEM-V

ASTROSTEM-V [WHO-DD]

COVI-MSC IS AN ALLOGENEIC CULTURE-EXPANDED ADIPOSE-DERIVED MESENCHYMAL STEM CELLS DERIVED FROM A DISEASE-SCREENED DONOR'S ADIPOSE TISSUE COLLECTED VIA LIPOSUCTION AND WHICH UNDERGOES TISSUE PROCESSING AND MANUFACTURING OF THE CELL PRODUCT UNDER GOOD MANUFACTURING PROCESSES. THE PRODUCT UNDERGOES VARIOUS PATHOGEN ASSESSMENTS AND PROCEDURES TO VERIFY FINAL PRODUCT STERILITY INCLUDING STERILITY BY DIRECT FILTRATION, MYCOPLASMA BY POLYMERASE CHAIN REACTION, AND ENDOTOXIN EVALUATION. A MAXIMUM OF 5 PASSAGES FROM THE MASTER CELL BANK (MCB) ARE USED FOR CULTURE EXPANSION TO MAINTAIN MSC VIABILITY

PSC-04 [WHO-DD]

RILDINADSTROCEL [INN]

RILDINADSTROCEL [USAN]